The secrets of the bone marrow niche: Metabolic priming for AML

Nature Medicine

Volumn 18, Issue 6, 2012, Pages 865-867

  Yusuf, Rushdia Z ^a   Wang, Ying Hua ^a   Scadden, David T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; DNA TOPOISOMERASE INHIBITOR;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER SUSCEPTIBILITY; GENETIC PREDISPOSITION; HUMAN; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; METABOLIC DISORDER; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NOTE; PRIORITY JOURNAL;

HUMANS; ISOCITRATE DEHYDROGENASE; LEUKEMIA, MYELOID, ACUTE; MYELODYSPLASTIC SYNDROMES; TUMOR MICROENVIRONMENT;

EID: 84862005167     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2831     Document Type: Note

References (18)

1. Li, L. et al. Cancer Cell 20, 591-605 (2011).
2. Davies, S.M. Med. Pediatr. Oncol. 36, 536-540 (2001).
3. Felix, C.A. Med. Pediatr. Oncol. 36, 525-535 (2001).
4. Rowe, J.M. Leukemia 16, 748-750 (2002).
5. Walter, M.J. et al. N. Engl. J. Med. 366, 1090-1098 (2012).
6. Bejar, R. et al. N. Engl. J. Med. 364, 2496-2506 (2011).
7. Warburg, O. Oncologia 9, 75-83 (1956).
8. Vander Heiden, M.G., Cantley, L.C. & Thompson, C.B. Science 324, 1029-1033 (2009).
9. Hitosugi, T. et al. Sci. Signal. 2, ra73 (2009).
10. Wang, Y. et al. Cell Stem Cell 8, 399-411 (2011).
11. Mardis, E.R. et al. N. Engl. J. Med. 361, 1058-1066 (2009).
12. Dang, L. et al. Nature 462, 739-744 (2009).
13. Figueroa, M.E. et al. Cancer Cell 18, 553-567 (2010).
14. Levine, A.J. & Puzio-Kuter, A.M. Science 330, 1340-1344 (2010).
15. Kranendijk, M. et al. Science 330, 336 (2010).
16. Schofield, R. Blood Cells 4, 7-25 (1978).
17. Greaves, M. & Maley, C.C. Nature 481, 306-313 (2012).
18. Zhang, W. et al. Nat. Cell Biol. 14, 276-286 (2012).